PGP 9.5 immunocytochemical staining for pancreatic endocrine tumors

Islets

Volumn 5, Issue 3, 2013, Pages 122-128

  Tomita, Tatsuo ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Insulinomas; Pancreatic endocrine tumors; Pancreatic islets; PGP9.5

Indexed keywords

CHROMOGRANIN A; GASTRIN; PANCREAS HORMONE; PROTEIN GENE PRODUCT 9.5; TUMOR MARKER; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; GASTRINOMA; GLUCAGONOMA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INSULINOMA; NERVE CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PANCREAS ISLET CELL TUMOR; PANCREAS ISLET DELTA CELL; PANCREAS TUMOR; PANCREATIC NEUROENDOCRINE TUMOR; PANCREATIC POLYPEPTIDOMA; SOMATOSTATINOMA;

INSULINOMAS; PANCREATIC ENDOCRINE TUMORS; PANCREATIC ISLETS; PGP9.5;

BIOLOGICAL MARKERS; GANGLIA; GLUCAGON-SECRETING CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-SECRETING CELLS; INSULINOMA; NEOPLASM GRADING; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; NEUROENDOCRINE CELLS; PANCREAS; PANCREATIC NEOPLASMS; UBIQUITIN THIOLESTERASE;

EID: 84886456318     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.25351     Document Type: Article

References (29)

1. Thompson RJ, Doran JF, Jackson P, Dhillon AP, Rode J. PGP 9.5-a new marker for vertebrate neurons and neuroendocrine cells. Brain Res 1983; 278:224-8; PMID:6640310; http://dx.doi.org/10.1016/0006-8993(83)90241-X (Pubitemid 14219291)
2. Rode J, Dhillon AP, Doran JF, et al. PGP 9.5, a new marker for human neuroendocrine tumors. Histopath 1985; 9:147-58; http://dx.doi.org/10.1111/j. 1365-2559.1985.tb02431.x (Pubitemid 15136720)
3. Day IN, Thompson RI. Molecular cloning of cDNA coding for human PGP9.5 protein. A novel cytoplasmic marker for neurons and neuroendocrine cells. FBES Lett 1987; 210:157-60; http://dx.doi.org/10.1016/0014-5793(87)81327-3 (Pubitemid 17002150)
4. Wilkinson KD, Lee KM, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J. The neuron-specific PGP9.5, an ubiquitin C-terminal hydrolase. Science 1989; 246:670-3; PMID:2530630; http://dx.doi.org/10.1126/science.2530630 (Pubitemid 19283361)
5. Wilson POG, Barber PC, Hamid QA, Power BF, Dhillon AP, Rode J, et al. The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies. Br J Exp Pathol 1988; 69:91-104; PMID:2964855
6. Schofield JN, Day IN, Thompson RJ, et al. PGP9.5, an ubiquitin C-terminal hydrolase: Patterns of mRNA and protein expression during neural development in the mouse. Brain Res Dev 1995; 85:229-38; http://dx.doi.org/10.1016/0165- 3806(94)00217-N
7. Klöppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 2004; 1014:13-27; PMID:15153416; http://dx.doi.org/10.1196/annals.1294.002 (Pubitemid 38594787)
8. Rindi G, Arnold R, Bosman FT. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Caneiro RH, Hruban RH, eds. WHO Classification of Tumours of the Digestive System. 4th ed. Lyon: IARC Press, 2010:13-14.
9. Lopes-Kruger R, Dockerty MB. Tumors of the islets of Langerhans. Surg Gynecol Obstet 1947; 85:485-511
10. Moldow RE, Connelly RR. Epidemiology of pancreatic cancer in Connecticut. Gastroenterology 1968; 55:677-86; PMID:4302500
11. Schein PS. Islet cell tumors: current concepts and management. Ann Intern Med 1973; 79:239-57; PMID:4147411; http://dx.doi.org/10.7326/0003-4819-79-2-239
12. Kimura W, Kuroda A, Morioka Y. Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci 1991; 36:933-42; PMID:2070707
13. Grimelius L, Hultquist GT, Steinkvist B. Cytological differentiation of asymptomatic pancreatic islet cell tumors in autopsy material. Virchows Archiv Pathol 1975; 365:275-88
14. Solcia E, Capella C, Kloppel G. Tumors of the endocrine pancreas. In: Atlas of Tumor Pathology. Tumors of the Pancreas. Washington, DC: AFIP, 1995:145-209.
15. Hruban RH, Pitman MB, Klimstra DS. Endocrine neoplasms. In: Tumors of the pancreas. Atlas of Tumor Pathology. Washington, DC: AFIP, 2007:251-303.
16. Adrian TE, Uttenthal LO, Williams SJ, Bloom SR. Secretion of pancreatic polypeptide in patients with pancreatic endocrine tumors. N Engl J Med 1986; 315:287-91; PMID:3014338; http://dx.doi.org/10.1056/NEJM198607313150504 (Pubitemid 16099973)
17. Ramage JK, Davies AHG, Ardill J, Bax N, Caplin M, Grossman A, et al.; Guideline for Neuroendocrine Tumours. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005; 54(Suppl 4):iv1-16; PMID:15888809; http://dx.doi.org/10.1136/gut.2004.053314
18. Tomita T, Friesen SR, Kimmel JR, Doull V, Pollock HG. Pancreatic polypeptide-secreting islet-cell tumors. A study of three cases. Am J Pathol 1983; 113:134-42; PMID:6314815 (Pubitemid 13023449)
19. Tomita T, Friesen SR, Kimmel JR. Pancreatic polypeptide-secreting islet cell tumor. A follow-up report. Cancer 1986; 57:129-33; PMID:3000569; http://dx.doi.org/10.1002/1097-0142(19860101)57:1129::AID-CNCR28205701263.0. CO;2-Q (Pubitemid 16212247)
20. Klöppel G, Rindi G, Anlauf M, Perren A, Komminoth P. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Arch 2007; 451(Suppl 1):S9-27; PMID:17684761; http://dx.doi.org/10.1007/s00428- 007-0461-0
21. Mori M, Yamada K, Takagi H, Shrestha P, Lee S. Protein gene product 9.5 (PGP9.5) immunoreactivity in salivary gland tumors. Oncol Rep 1996; 3:249-54; PMID:21594353 (Pubitemid 26075620)
22. Doran JF, Jackson P, Kynoch PA, Thompson RJ. Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis. J Neurochem 1983; 40:1542-7; PMID:6343558; http://dx.doi.org/ 10.1111/j.1471-4159.1983.tb08124.x (Pubitemid 13106931)
23. Fried VA, Smith HT, Hildebrandt E, Weiner K. Ubiquitin has intrinsic proteolytic activity: implications for cellular regulation. Proc Natl Acad Sci U S A 1987; 84:3685-9; PMID:3035547; http://dx.doi.org/10.1073/pnas.84.11.3685 (Pubitemid 17088346)
24. Karanth SS, Springall DR, Kuhn DM, Levene MM, Polak JM. An immunocytochemical study of cutaneous innervation and the distribution of neuropeptides and protein gene product 9.5 in man and commonly employed laboratory animals. Am J Anat 1991; 191:369-83; PMID:1719791; http://dx.doi.org/10.1002/aja.1001910404
25. Tomita T. Caspase-3 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors. Hum Pathol 2009; 40:1050-2; PMID:19427666; http://dx.doi.org/10.1016/j.humpath.2009.02.010
26. Tomita T. Lymphatic vessel endothelial hyaluronan receptor 1 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors. Pancreas 2007; 35:e18-22; PMID:18090227; http://dx.doi.org/10.1097/MPA. 0b013e318068fcba (Pubitemid 350307392)
27. Rodriguez-Diaz R, Abdulreda MH, Formoso AL, Gans I, Ricordi C, Berggren PO, et al. Innervation patterns of automatic axons in the human endocrine pancreas. Cell Metab 2011; 14:45-54; PMID:21723503; http://dx.doi.org/10.1016/j. cmet.2011.05.008
28. Tomita T. DNA ploidy and proliferating cell nuclear antigen in islet cell tumors. Pancreas 1996; 12:36-47; PMID:8927618; http://dx.doi.org/10.1097/ 00006676-199601000-00005 (Pubitemid 26004500)
29. Tomita T. Metallothionein in pancreatic endocrine neoplasms. Mod Pathol 2000; 13:389-95; PMID:10786804; http://dx.doi.org/10.1038/modpathol.3880064 (Pubitemid 30225226)